Literature DB >> 12511059

Treating cocaine-using methadone patients: predictors of outcomes in a psychosocial clinical trial.

Stephen Magura1, Andrew Rosenblum, Chunki Fong, Cherie Villano, Beverly Richman.   

Abstract

Cocaine-using methadone patients in two clinics were assigned to 8 months of enhanced methadone treatment-primarily cognitive-behavioral therapy (CBT) for cocaine use-while similar patients in two "sibling" clinics were assigned to standard methadone treatment during 1995-1998. Cocaine use declined significantly from baseline to 4- and 12-month follow-ups. Patients receiving CBT rated the quality of their counseling relationship higher and obtained more supportive services than those receiving standard treatment. However, study treatment condition itself was not associated with outcome. Baseline measures associated with poorer outcomes across both treatment conditions were: currently enrolled in methadone treatment (in contrast to being newly enrolled), higher cocaine use frequency, greater cocaine use associated problem recognition, and an ambivalent attitude toward methadone. The results are consistent with some previous clinical trials showing that psychosocial treatments of different intensities result in similar declines in cocaine use. The findings indicate that methadone maintenance treatment can help dually-addicted patients reduce their cocaine use.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12511059     DOI: 10.1081/ja-120016225

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  11 in total

1.  "It Ruined My Life": The effects of the War on Drugs on people who inject drugs (PWID) in rural Puerto Rico.

Authors:  R Abadie; C Gelpi-Acosta; C Davila; A Rivera; M Welch-Lazoritz; K Dombrowski
Journal:  Int J Drug Policy       Date:  2017-07-14

2.  Comparison of demographic and clinical characteristics between opioid-dependent individuals admitted to a community-based treatment setting and those enrolled in a research-based treatment setting.

Authors:  C Patrick Carroll; Michael Kidorf; Eric C Strain; Robert K Brooner
Journal:  J Subst Abuse Treat       Date:  2007-04-02

3.  Challenging biopower: "Liquid cuffs" and the "Junkie" habitus.

Authors:  Camila Gelpi-Acosta
Journal:  Drugs (Abingdon Engl)       Date:  2014-12

4.  Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients.

Authors:  Alison Oliveto; James Poling; Michael J Mancino; Zachary Feldman; Joseph F Cubells; Rhonda Pruzinsky; Kishorchandra Gonsai; Christopher Cargile; Mehmet Sofuoglu; Mohit P Chopra; Gerardo Gonzalez-Haddad; Kathleen M Carroll; Thomas R Kosten
Journal:  Drug Alcohol Depend       Date:  2010-09-15       Impact factor: 4.492

5.  Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase.

Authors:  Thomas R Kosten; Guiying Wu; Wen Huang; Mark J Harding; Sara C Hamon; Jaakko Lappalainen; David A Nielsen
Journal:  Biol Psychiatry       Date:  2012-08-18       Impact factor: 13.382

6.  ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse.

Authors:  Catherine J Spellicy; Thomas R Kosten; Sara C Hamon; Mark J Harding; David A Nielsen
Journal:  Pharmacogenet Genomics       Date:  2013-07       Impact factor: 2.089

7.  Correlates of stimulant treatment outcome across treatment modalities.

Authors:  Jessica M Peirce; Nancy M Petry; John M Roll; Ken Kolodner; Joe Krasnansky; Patricia Q Stabile; Chanda Brown; Maxine L Stitzer
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

8.  The North American Opiate Medication Initiative (NAOMI): profile of participants in North America's first trial of heroin-assisted treatment.

Authors:  Eugenia Oviedo-Joekes; Bohdan Nosyk; Suzanne Brissette; Jill Chettiar; Pascal Schneeberger; David C Marsh; Michael Krausz; Aslam Anis; Martin T Schechter
Journal:  J Urban Health       Date:  2008-08-29       Impact factor: 3.671

9.  [Current consumer conditions among opioid addicts--implications for maintenance-treatment programmes provided by ambulatory drug treatment centers and physicians].

Authors:  Salvatore M Giacomuzzi; Markus Ertl; Yvonne Riemer; Haimo Rössler; Alexander Vigl; Hartmann Hinterhuber; Markus Kurz
Journal:  Wien Klin Wochenschr       Date:  2004-02-28       Impact factor: 1.704

Review 10.  A review of research-supported group treatments for drug use disorders.

Authors:  Gabriela López; Lindsay M Orchowski; Madhavi K Reddy; Jessica Nargiso; Jennifer E Johnson
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.